RareStone Group
RareStone Group is dedicated to building the first rare disease ecosystem in China to bring support network and much-needed treatments to improve the lives of patients and families impacted by rare diseases. Their mission is to provide access to the best, most effective medicines, and treatment protocols available in the world. RareStone Group Group consists of two business subsidiaries: Citrine Medicine and Zircon Health.
Alliance Members
Territories
We offer a single entry point for our partners with orphan portfolios in CEE, LATAM, MENAT, China, Cyprus, Greece, Israel, Malta, Russia and CIS, and Switzerland.
Together we can achieve more.
With deep understanding of local healthcare systems, we can support our partners to expand their business throughout the complex WODA regions.
